Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00101881 · ClinicalTrials.gov registry record · Phase 4
Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 168
- Enrollment target
NCT00101881 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 168 participants.
The verdict
NCT00101881, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 168 participants
- Enrollment target
Study Summary
The study compares the effectiveness of two fully approved shock waveforms (monophasic and biphasic shock) commonly used to defibrillate (shock) patients with out-of-hospital cardiac arrest due to a highly lethal rhythm problem (ventricular fibrillation). The purpose of the study (hypothesis) is to determine if one waveform results in improved resuscitation, admission alive to hospital, and discharge alive from hospital compared with the other.
Interventions
- DEVICE Defibrillation (biphasic versus monophasic shock)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00101881
The ClinicalTrials.gov registry entry for NCT00101881 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Defibrillation (biphasic versus monophasic shock) is the first listed.
NCT00101881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00101881 about?
NCT00101881 is a clinical study titled "Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)". The study compares the effectiveness of two fully approved shock waveforms (monophasic and biphasic shock) commonly used to defibrillate (shock) patients with out-of-hospital cardiac arrest due to a highly lethal rhythm problem (ventricular fibrillation). The purpose of the study (hypothesis) is to ...
What is the current status of trial NCT00101881?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 168 participants. The study started on 2002-11. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00101881?
The interventions under investigation include: Defibrillation (biphasic versus monophasic shock) (DEVICE).
Who is sponsoring clinical trial NCT00101881?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.